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Abstract
Background: High risk human papillomavirus (HR HPV) infects cells at the squamocolumnar junction (SCJ) of the
cervix, causing cancer. Cytokeratin (CK)7 is an SCJ marker, and stains cervical neoplasia. CK19 is a binding partner
of CK7 and expressed in cervical cancer. Despite this possible association between CK7/CK19 and cervical cancer,
not much is known about the mechanism of CK7/CK19 involvement in HR HPV-mediated cervical carcinogenesis.
Methods: We analyzed the expression pattern of CK7, CK19, and p16 by using immunohistochemistry and HPV
infection by in situ hybridization in 25 cases of high grade cervical intraepithelial neoplasia (CIN3) and in 30 cases
of squamous cell carcinoma (SCC).
Results: CK19, p16, and HPV expression was positive in all CIN3 and SCC cases. CK7 expression was positive in all
CIN3 cases and in 20/30 (66%) SCCs. Each protein showed diffuse or patchy staining with topographic distinction.
Patchy staining of CK7 and episomal HPV DNA overlapped in the upper layer of CIN3 and central portion of an
invasive nest in the SCC, whereas patchy CK19 staining and integrated HPV DNA were usually noted in the lower
layer of CIN3 and the periphery of the SCC nest. The p16 staining pattern coincided with that of CK19 in a subset
of SCC.
Conclusion: These results suggest that CK7 may be more related with viral episomal replication and CK19 with
viral integration, contributing to viral replication and malignant transformation in HR HPV infected cells. In addition,
coordinate CK7/CK19 staining may be used as a valuable marker for predicting physical status of HR HPV and E7
oncoprotein level in cervical tumor.
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Background
More than 200 human papillomavirus (HPV) types have
different epithelial tropisms and high risk (HR) HPV in-
fects the cervical epithelium, causing cancer [1]. Discrete
cell population at squamocolumnar junction (SCJ) of the
cervix is hypothesized as the source of HR HPV
infection and initiation site of cervical cancer [2–4]. SCJ
cells are identified as residual embryonic cells vulnerable
to neoplastic transformation [3]. Cytokeratin (CK)7,
AGR2, CD63, MMP7, and GDA are known as SCJ cell
markers [2, 5]. In normal-appearing SCJ cells positive
for CK7, HPV E2 (an early marker of HPV infection) is
expressed and HPV E6/E7 mRNA are detected, support-
ing the role of these cells in cervical carcinogenesis [4].
CK7 is also expressed in most cervical intraepithelial
neoplasia (CIN) and carcinomas [2, 6]. Moreover, CK7
positive CIN1 is more likely to progress to CIN3
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compared with CK7 negative CIN1, suggesting that CK7
is a predictive marker for CIN3 progress [6].
CK19 pairs with CK7 in simple epithelia and with
CK8/18 in stratified squamous epithelial cells [7]. In the
normal cervix, CK19 and CK7 stain endocervical colum-
nar and reserve cells and CK19 additionally stains basal
layer cells of ectocervix [8, 9]. Like CK7, CK19 is also
expressed in CIN, squamous cell carcinoma (SCC), and
adenocarcinoma [8, 9]. Thus, CK19 and CK7 positive
endocervical reserve cells were suggested as progenitor
cells of cervical cancer [8, 9] before the concept of SCJ
cell emerged. Despite this common expression of CK7
and CK19 in the normal cervix and cervical neoplasia,
little is known about the association between CK7 and
CK19 and HPV in cervical carcinogenesis.
HPV DNA exists as episomal or integrated state in
cervical neoplasia [10–13]. In CIN1, HR HPV genomes
persist in episomal form, whereas in CIN3 and carcin-
omas, the majority of HPV genomes are found in inte-
grated form [10, 12]. Integration of the HR HPV genome
into the human chromosome disrupts viral E2 gene, a
transcriptional repressor of the oncogenes E6 and E7,
resulting in the stabilization of oncogene transcription
[14]. E7 oncoprotein binds to retinoblastoma protein
(Rb), leading to loss of cell-cycle control. Rb inhibits
transcription of p16, a cyclin-dependent kinase inhibitor
[15]. Functional inactivation of Rb by E7 results in p16
overexpression, and p16 is used as a surrogate marker
for E7 protein [15]. Therefore, E2 and E7 expression is
in the negative link in CIN [16].
During HPV life cycle, the viral replication and the ex-
pression of viral genes are closely tied to the differenti-
ation program of host epithelial cell [1]. In this process,
CK network appears to be reorganized and regulated by
viral proteins [17]. Viral E4 protein is thought to partici-
pate in CK disruption, virus release and transmission [17].
Different viral protein expression according to the layer of
CIN may be related with different CK expression patterns
depending on the layer and the grade of CIN [9, 16]. In-
deed the expression of E2 and E7, represented by p16 is
mutually exclusive and shows topological distinction and
association with specific CKs in CIN [16]. Comprehensive
expression of CK subtypes had been described in CIN and
cancers [9], but the association between HPV status and
CK subtypes, especially CK7 and CK19 in cervical cancer
has not been studied. Thus, in this study, we analyzed the
expression of CK7, CK19, and p16, and physical status of
HPV in CIN3 and SCC to investigate their possible associ-
ation in cervical carcinogenesis.
Methods
Tissue samples
The list of CIN and SCC was obtained from archives in
the Department of Pathology at Nowon Eulji Medical
Center, Eulji University. We retrieved 25 CIN3 and 30
SCC cases collected by cone biopsy, loop electrosurgical
excision procedure (LEEP), or hysterectomy. The age of
all CIN3 and SCC patients ranged from 27 to 79 years
and the mean was 48 years. The stage of 30 SCC pa-
tients was classified into 11 cases of stage Ia, 10 stage Ib,
5 stage II, 3 stage III, and 1 stage IV according to the
International Federation of Gynecology and Obstetrics
staging. Ten non-neoplastic cervical specimens from the
uteri removed for non-cervical pathologic conditions
were also included. After reviewing all hematoxylin and
eosin (HE) stained slides from each case, representative
blocks for each case were selected. In two cases of CIN3
(LEEP) and one case of SCC (LEEP), immunohistochem-
ical evaluation was not available in the slides made from
initially selected blocks by repeat cutting due to tech-
nical reasons and other blocks for the same case were
used for immunohistochemistry. This study was per-
formed with the approval of the Institutional Review
Board of Nowon Eulji Medical Center.
Immunohistochemistry
Immunohistochemical staining was performed using
Dako Autostainer (DakoCytomation, Carpinteria, CA,
USA). Four micron tissue sections were cut from se-
lected blocks and positioned on poly-L-lysine coated
slides. After deparaffinization and rehydration, antigen
retrieval was performed using citrate buffer (pH 6.0) at
121 °C for 10 min. Endogenous peroxidase activity was
blocked by 3% hydrogen peroxide for 5 min. The
primary antibodies used in this study were CK7 (Dako,
Carpinteria, CA, 1:100), CK19 (Dako, 1:100), and p16
(Dako p16INK4a kit). Color was developed with diami-
nobenzidine, and the slides were counterstained with
hematoxylin.
Immunostaining assessment
CK7 and CK19 staining was interpreted as positive when
approximately five to six contiguous cells showed cyto-
plasmic and/or membranous block staining [6]. With
p16, nuclear or nuclear and cytoplasmic block staining
was considered positive [18]. The immunoreactivity of
CK7, CK19, and p16 was determined by assessing the
staining intensity and percentage of stained cells. The
staining intensity was rated as weak, moderate, and
strong. The percentage of positive cells was scored as
follows: negative – staining in less than 1% of cells,
patchy – staining in 1% to 40% of cells, and diffuse –
staining over more than 40% of cells.
In situ hybridization
In situ hybridization (ISH) was performed using the
INFORM HPV III Family 16 Probe (B) (Ventana
Medical Systems, Tucson, AZ, USA), according to the
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manufacturer’s recommendations. The probe cocktail
has demonstrated affinity for the following HR HPV
genotypes: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and
66. The HPV signal patterns were classified as the
episomal or integrated form, found within the nuclei of
cervical epithelial cells. The episomal HPV was defined
as large globular dense nuclear staining. The integrated
HPV was defined as discrete dot-like signals or scattered
tiny particles in the nuclei.
Results
Expression of CK7 and CK19 in non-neoplastic cervix
In the non-neoplastic cervix (Fig. 1a), CK7 staining was
strong in the columnar cells at the SCJ, faintly seen in
the cells at the transformation zone (Fig. 1b), and nega-
tive in squamous cells at the ectocervix. CK19 was
weakly stained in the columnar cells at the SCJ, squa-
mous cells at the transformation zone (Fig. 1c), and
basal layer cells at the ectocervix.
Expression of CK7, CK19, p16, and HPV in CIN3
The results of immunohistochemistry for CK7, CK19,
and p16 in CIN3 are shown in Fig. 2 and their detailed
expression patterns and HPV status are demonstrated in
Fig. 3. The expression of CK7, CK19, and p16 was posi-
tive in all of 25 CIN3 cases. There were 12 (48%) patchy
stained cases of CK7, and 10 (40%) of CK19, topograph-
ically distinct. Patchy CK7 expression was usually seen
in the upper layer of CIN3, most intensely in the superfi-
cial layer and gradually weaker in the lower layer. In
some cases of CIN3 located in the ectocervix (CIN3#12,
Fig. 4a), CK7 staining was strong in the cells in the
upper layer (Fig. 4d). Conversely, patchy CK19 expres-
sion was most intense in the basal layer of CIN3 and
gradually weaker toward the upper layer (Fig. 4g). Dif-
fuse staining of CK7 was seen in 13 (52%) and 15 (60%)
cases of CK19, with homogeneous expression in entire
layer of CIN3 located at the transformation zone
(CIN3#21, Fig. 4b, e and h) and the SCJ (CIN3#23,
Fig. 4c, f and i). p16 expression was diffuse in all CIN3
cases with moderate (Fig. 4j and l) to strong intensity
(Fig. 4k).
HPV was detected in all CIN3 cases including 11
(44%) cases with combined episomal and integrated
form and 14 (56%) cases with integrated form. Episomal
HPV DNA was usually seen in the upper layer corre-
sponding with CK7 staining area (Fig. 4m and o), while
integrated HPV DNA was noted in entire layer (Fig. 4n).
Expression of CK7, CK19, p16, and HPV in SCC
The results of immunohistochemistry for CK7, CK19,
and p16 in SCC are shown in Fig. 5 and their detailed
expression patterns and HPV status are demonstrated in
Fig. 6. While the expression of CK19 and p16 was posi-
tive in all 30 SCC cases, CK7 expression was positive in
20 cases (67%) and negative in 10 cases (33%). Patchy
staining of CK7 was seen in 13 (43%) and 19 cases (63%)
of CK19. Of the typical SCCs (13 cases, 43%) showing
solid tumor nests with/without keratinous pearl (SCC#8,
Fig. 7a), CK7 staining was positve in 8 cases (62%) and
negative (Fig. 7d) in 5 cases while CK19 staining was
positive (Fig. 7g) in all cases. Interestingly, in the case of
SCC#28, CK7 staining was noted in a keratinizing tumor
nest. Topologically distinctive staining pattern of CK7
and CK19 was seen in SCC with central cystic space
within the tumor nest, such as SCC#19. In SCC#19
(Fig. 7b), CK7 staining was diffusely positive in overall
tumor nest but stronger in the cells of inner portion of
the nest and cellular debris shedding within the space
(Fig. 7e). However, CK19 positive cells were patchily
present along the periphery of the invasive tumor nests
(Fig. 7h) (Addittional File 1: Figure S1). The central cys-
tic space within the tumor nest was seen in 14 cases
(47%) and 10 of 14 cases (71%) were positive for CK7. In
SCC showing infiltrating cord-like or branching growth
pattern (Fig. 7c), CK7 and CK19 staining was both dif-
fuse and strong in the tumor cells, and their staining
was intensified in the invasive front and tumor cells with
Fig. 1 Expression of CK7 and CK19 in non-neoplastic cervix. HE staining shows the transformation zone and SCJ cells (arrow) (a). Strong CK7
staining is seen in the columnar cells at the SCJ with faint staining of CK7 in the squamous cells at the transformation zone (b). Weak staining
of CK19 is seen in the columnar cells at the SCJ and the squamous cells at the transformation zone (c). Original magnifications: x400
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glandular differentiation (SCC#29, Fig. 7f and i). This
growth pattern was seen in 3 cases (10%) and 2 of 3
cases (67%) were positive for CK7. Despite strong CK7
and CK19 expression in a subset of SCC, overall staining
of CK7 and CK19 in SCC was weaker than that in CIN3
The expression of p16 was also weaker in SCC com-
pared with CIN3, with even one patchy stained case
(SCC#20, Fig. 6). In SCC#19, the staining of p16 was dif-
fuse but disappeared toward the inner portion of the
nest (Fig. 7k). It was notable that in SCC with diffuse
and strong CK7 staining, p16 staining was weak
(SCC#29, Fig. 7l), whereas in SCC with no CK7 staining,
p16 staining was strong (SCC#8, Fig. 7j), suggesting an
inverse correlation between CK7 and p16 in SCC,
although not consistent in all cases.
HPV was positive in all SCC samples, displaying mixed
episomal and integrated form in 14 (47%) and integrated
form in 16 (53%) of 30 SCC cases. The cases with inte-
grated HPV DNA revealed no topographic distinction.
In SCC#19, an episomal form was seen in the entire
tumor nest but more frequently in central portion of the
nest, overlapping with the expression of CK7 (Fig. 7n).
However, an episomal HPV was not always concordant
with CK7 expression because HPV with the integrated
form only was also seen in tumor cells with strong CK7
positivity such as SCC#29 (Fig. 7o). Inversely, in CK7
negative case such as SCC#8, an episomal form of HPV
DNA was also noted (Fig. 7m).
Discussion
In this study, we found consistent expression of CK19,
p16, and HR HPV in CIN3 and SCC cases. However,
CK7 expression was lost in one-third of SCC cases,
although its expression was positive in all CIN3 cases.
CK7 and CK19 showed topographic distinction in patchy
stained CIN3 and SCC cases. In addition, CK7 and
CK19 staining appeared to be more linked with episomal
and integrated forms of HPV, respectively. The expres-
sion of CK7 or CK19 has been intensely studied in HPV
mediated oropharyngeal SCC as well as cervical
neoplasia [2–4, 19, 20]. However, the mechanism of CK7
and CK19 involvement in HPV positive cancer is largely
unknown. Only a few studies provide clues to this by
examining the relationship between HPV16 E7 and
CK19/CK7 in cervical cancer cell lines [21–23].
In SiHa cells, HPV16 E7 mRNA interacts with the 6-
mer peptide SEQIKA of CK7 and E7 mRNA translation
is inhibited [22]. In contrast, CK19 promotes the transla-
tion of E7 mRNA into the oncoprotein by binding to the
CK7 SEQIKA peptide [23]. Favia et al [21] show that in
Fig. 3 Expression profile of CK7, CK19, p16, and HR HPV in CIN3
Fig. 2 The result of CK7, CK19, and p16 expression in CIN3
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SiHa cells, which have CK19 and CK7, higher E7 protein
level is detected notwithstanding low copies of HPV16
DNA per cell compared to CaSki cells, which have only
CK7 and shows low E7 protein in spite of a high number
of HPV16 DNA per cell [21]. These results suggest a dif-
ferential role of CK7 and CK19 on HPV16 E7 oncopro-
tein expression, such as CK7 as a protector of E7
transcript and CK19 as an enhancer of E7 mRNA trans-
lation into the oncogenic product [21]. The present
study showed mutually exclusive expression of CK7 and
CK19 and concordant expression of CK19 and p16 in a
subset of CIN3 and SCC, in agreement with the
literature.
In CIN1, CK7 staining is predominantly strong in the
surface epithelial cells [3, 6]. As the lesion is proceeding
to CIN2/3, CK7 stain is extending down toward the
basal layer (top down expression), recapitulating cervical
development during fetal period [3, 9]. Given that CK7
is consistently stained in the SCJ cells and the upper
layer cells in immature metaplasia and all grades of CIN
[2–4, 16], it would be assumed that CK7 positive cells in
the luminal side of an invasive cancer nest (SCC#19)
might be the cells line in this sequence. However, why
these CK7 positive cells persist in the upper layer of cer-
vical lesions and how they participate in the neoplastic
process are unclear. Presumably, HR HPV infected SCJ
cells induce proliferation of CK7 positive cells more ba-
sally, functioning as progenitor cells of cervical neoplasia
[3]. Otherwise, prior to or in concert with HR HPV
infection, residual embryonic SCJ cells may migrate
towards adjacent squamous cells upon injury or inflam-
mation, followed by downward clonal expansion of CK7
positive metaplastic or dysplastic cells, similar to that
seen in Barrett’s esophagus [24].
CK19 expression extends upward from the basal to
superficial layer (bottom up expression) as CIN grade is
increasing [8, 9]. p16 stains similarly to CK19 with the
severity of CIN [12]. This might be related to the
Fig. 4 Expression pattern of CK7, CK19, p16, and HR HPV in CIN3. HE staining shows representative CIN3s developing in the ectocervix (CIN3#12)
(a), transformation zone (CIN3#21) (b), and SCJ (CIN3#23) (c), respectively. CIN3#12 shows patchy staining of CK7 in the upper layer (d), patchy
staining of CK19 in the lower layer (g), diffuse staining of p16 (j), mixture of episomal and integrated HPV with remarkable episomal form in the
upper layer (m). CIN3#21 and CIN3#23 show diffuse staining of CK7 (e and f), CK19 (h and i), and p16 (k and l). HPV is present in integrated form
in CIN3#21 (n) and mixed episomal and integrated form in CIN3#23 (o). Original magnifications: x400
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function of CK19 promoting the translation of E7
mRNA into the oncoprotein as previously discussed [21,
23]. This upward expression pattern of CK19 supports
the traditional view that HR HPV first infects exposed
basal cells and transformed basal cells divide and mi-
grate upward following squamous epithelial differenti-
ation program [1, 25]. Indeed CK19 is a stem cell
marker in skin and squamous epithelia-lined mucosa
such as the oral cavity [26, 27]. CK19 staining is nega-
tively associated with the expression of involucrin, ter-
minal differentiation protein in oral epithelium,
suggesting that CK19 expression may be linked to the
retention of stem cell character [26]. The stem cells re-
tain a high capacity for self-renewal and a large prolifer-
ative potential [27]. Therefore, the basal cells of the
ectocervix would be preferential site for HPV infection if
viruses can access these cells probably through a micro-
wound [1]. Presumably, basal expression of CK19 and
HPV in CIN3#12 of the present study reflects basal cells
infected by HR HPV in the ectocervix, similar to skin
and oral cavity.
In the present study, CK19 and CK7 were both stained
at the cells of the transformation zone and SCJ of the
non-neoplastic cervix, although staining intensity of
CK19 was weaker than that of CK7 in SCJ. In normal
human organs, co-expression of CK7 and CK19 occurs
in hepatic progenitor cells, which are capable of differen-
tiating into hepatocytes and cholangiocytes [28]. If SCJ
cells of the cervix function as progenitor cells, like hep-
atic progenitor cells, SCJ cells would be capable of dif-
ferentiating into squamous cell and columnar cell and
evolving into CIN showing squamous and columnar cell
feature, such as CIN3#21 and CIN3#23, respectively. We
found that CK7 and CK19 were diffusely co-expressed in
CIN3#21 and CIN3#23, which occurred in the trans-
formation zone and SCJ, respectively. CK7 and CK19 ex-
pression was mutually exclusive and patchy in CIN3#12,
which occurred in the ectocervix close to the transform-
ation zone. These results suggest that the expression
Fig. 5 The result of CK7, CK19, and p16 expression in squamous
cell carcinoma
Fig. 6 Expression profile of CK7, CK19, p16, and HR HPV in squamous
cell carcinoma
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pattern of CK7 and CK19 might indicate the location of
the cervix in which CIN3 arises, although not consist-
ently. In SCC, the expression pattern of CK7 and CK19
was variable depending on the tumor nests within the
same tumor; thus the initial cancer site could not be
predicted. Nevertheless, SCC showing glandular differ-
entiation and diffuse expression of CK7 and CK19 such
as SCC#29 might arise from SCJ. Likewise, SCC showing
patchy expression for CK19 with/without CK7 might re-
flect the cancer developed from ectocervix, where CK19
stain is consistently present in basal layer cells, while
CK7 stain is sporadically noted in the upper layer close
to the SCJ. Thus, presumably CK19 is a common pro-
genitor cell marker of cervix cancer developing in the
SCJ and ectocervix.
In cervical cancer, HR HPV is mainly detected in inte-
grated form [10, 11, 29], although there are studies
showing dominant episomal form or mixed episomal
and integrated form in cancer biopsy specimens [12, 13].
HPV integration seems to contribute to the stabilization
of oncogene transcription [29]. Thus, diffuse expres-
sion of p16 in CIN3 and SCC in the present study
might represent stable E7 production through HPV
integration. In the present study, integration of HR
HPV was found in all cases and episomal HPV DNA
was observed in 44% (11/25 cases) of CIN3 and 47%
(14/30 cases) of SCC. Both episomal and integrated
HPV DNA coexist in the same tumor cell nuclei [11].
E2 is not only a transcriptional repressor of E6 and E7,
but also required for viral genome replication [1, 16].
Therefore, E2 protein from coexisting intact episomal
E2 gene could replace the regulatory function of an
integrated defective E2 gene [11]. In some cases of
the present study, episomal HPV overlapped with
CK7 expression in the upper layer of CIN3
(CIN3#12) and SCC with cystic tumor nest (SCC#19),
suggesting possible association between CK7 and viral
genome replication. Although CK7 is known to be
Fig. 7 Expression pattern of CK7, CK19, p16, and HR HPV in squamous cell carcinoma (SCC). HE staining shows SCC with solid tumor nests
(SCC#8) (a), SCC with cystic change (SCC#19) (b), and SCC with glandular differentiation (SCC#29) (c). CK7 staining is negative in SCC#8 (d) and
diffusely positive in SCC#19 (e) and SCC#29 (f). CK19 staining pattern is patchy in SCC#8 (g) and SCC#19 (h), and diffuse in SCC#29 (i). p16
staining is diffusely positive with variable intensity in SCC#8 (j), SCC#19 (k), and SCC#29 (l). HPV is present in mixture of episomal and integrated
form in SCC#8 (m) and predominant episomal form in the cystic tumor nest and cellular debris shedding within the cystic space of SCC#19 (n),
and integrated form in SCC#29 (o). Original magnifications: (a), (c), (d), (f), (g), (i), (j), (l), (m), and (o) x400; (b), (e), (h), (k) and (n) x200
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involved in regulating E7 transcript [21], whether
CK7 plays a role in the process of viral replication is
unclear. However, considering that CKs including
CK7 regulate protein biosynthesis through localization
of glucose transporter and activation of mTOR path-
way [30], CK7 might be essential for production of
proteins for viral replication and assembly. Moreover,
CK7 is commonly expressed in most secretory cells of
human organ [31], thus CK7 positive cells with
secretory property in the upper layer of CIN3 and
inner surface of SCC nests would be advantageous for
viral release after viral particles are generated.
There are still questions left unresolved in this study.
The first is how the cells with stem cell character were
simultaneously present in the upper layer and the lower
layer of CIN3 showing CK7 and CK19 positivity,
respectively as shown in CIN3#12. One possible explan-
ation would be concurrent neoplastic transformation of
CK7 positive cells in the upper layer derived from SCJ and
CK19 positive basal stem cells in the lower layer infected
by different or multiple HR HPV [32, 33]. CIN3#12 in this
study might imply coexistent CIN lesion from different cell
clones lying in the upper and lower layer cells infected by
different HPV types [33], although HPV typing is required.
The second question is why CK7 expression was
not observed in 10 of 30 cases of SCC whereas CK19
expression was retained even with a patchy pattern in
all SCC cases. This might be related to a basically dif-
ferent expression level of CK7 and CK19 depending
on the location in the cervix in which SCC arises. As
CK7 was not detected in the ectocervix distant to
SCJ, SCC developed from this area would show only
CK19 positivity. However, it remains to be explored
why CK7 and CK19 did not co-localize to the same
tumor cell populations despite their pairing property.
The last one is why the expression of CK19 as well as
CK7 was lower or weaker in SCC compared to CIN3.
Changes of CK7 and CK19 expression level in invasive
cancer compared with CIN3 might be related to migra-
tion capacity of cancer cells [34] or asymmetric division
of CK7 and/or CK19 positive progenitor cells during
cancer progression [35].
Conclusions
In conclusion, our results support earlier studies in
which CK7 might be a predictive marker for HPV infec-
tion and CIN3 progress. In addition, consistent expres-
sion of CK19 and p16, accompanied by HPV integration
in CIN3 and SCC tissues supports the idea that CK19
may promote E7 oncoprotein production, contributing
carcinogenic events. We suggest that coordinate CK7/
CK19 staining may be used as a valuable marker for pre-
dicting the physical status of HR HPV and E7 level in
cervical tumor.
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